Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Julius-Maximilians-Universitat Wurzburg”

39 pharma patents match "Julius-Maximilians-Universitat Wurzburg" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 39
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 39 pharmaceutical patents matching "Julius-Maximilians-Universitat Wurzburg" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

39 results for “Julius-Maximilians-Universitat Wurzburg” · 30,257 patents in full index Clear search

  1. US 12168718

    Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted

  2. US 12018125

    Block-copolymers for the delivery of active agents

    Julius-Maximilians-Universitat Wurzburg · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted

  3. US 11891436

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Julius-Maximilians-Universitat Wurzburg · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted

  4. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  5. US 11634482

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  6. US 11464856

    Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  7. US 11427644

    Dual antigen-induced bipartite functional complementation

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  8. US 11206824

    Gas delivery device comprising a gas releasing molecule and a gas permeable membrane

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  9. US 11149073

    ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  10. US 11028144

    Soluble glycoprotein V for treating thrombotic diseases

    Julius-Maximilians-Universitat Wurzburg · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  11. US 10781251

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  12. US 10604565

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  13. US 10513532

    Compound containing dexpanthenol

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  14. US 10434117

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  15. US 10261095

    Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  16. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  17. US 10105414

    Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  18. US 10028974

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  19. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Julius-Maximilians-Universitat Wurzburg · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  20. US 9814789

    Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

    Julius-Maximilians-Universitat Wurzburg · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  21. US 9663788

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted May 30, 2017 · Expires May 25, 2037

    granted

  22. US 9526803

    Diagnostic chewing gum for pathogens

    Julius-Maximilians-Universitat Wurzburg · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  23. US 9422365

    Peptide or arrangement of peptides forming a Staphylococcus aureus epitope binding site

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  24. US 9260511

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Julius-Maximilians-Universitat Wurzburg · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.